FR2068412A1 - - Google Patents

Info

Publication number
FR2068412A1
FR2068412A1 FR6935974A FR6935974A FR2068412A1 FR 2068412 A1 FR2068412 A1 FR 2068412A1 FR 6935974 A FR6935974 A FR 6935974A FR 6935974 A FR6935974 A FR 6935974A FR 2068412 A1 FR2068412 A1 FR 2068412A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6935974A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ugine Kuhlmann SA
Original Assignee
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE757653D priority Critical patent/BE757653A/fr
Application filed by Ugine Kuhlmann SA filed Critical Ugine Kuhlmann SA
Priority to FR6935974A priority patent/FR2068412A1/fr
Priority to US00082556A priority patent/US3737524A/en
Priority to DE19702051745 priority patent/DE2051745A1/de
Priority to GB49882/70A priority patent/GB1294580A/en
Priority to JP45092115A priority patent/JPS502008B1/ja
Priority to NL7015376A priority patent/NL7015376A/xx
Publication of FR2068412A1 publication Critical patent/FR2068412A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
FR6935974A 1969-10-21 1969-10-21 Withdrawn FR2068412A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BE757653D BE757653A (fr) 1969-10-21 Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
FR6935974A FR2068412A1 (fr) 1969-10-21 1969-10-21
US00082556A US3737524A (en) 1969-10-21 1970-10-20 Medicaments derived from nucleic acids,processes for their preparation and their use
DE19702051745 DE2051745A1 (de) 1969-10-21 1970-10-21 Von Nucleinsäuren stammende Arznei mittel und Verfahren zu ihrer Herstellung
GB49882/70A GB1294580A (en) 1969-10-21 1970-10-21 New medicaments derived from nucleic acids, processes for their preparation and their use
JP45092115A JPS502008B1 (fr) 1969-10-21 1970-10-21
NL7015376A NL7015376A (fr) 1969-10-21 1970-10-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6935974A FR2068412A1 (fr) 1969-10-21 1969-10-21

Publications (1)

Publication Number Publication Date
FR2068412A1 true FR2068412A1 (fr) 1971-08-27

Family

ID=9041804

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6935974A Withdrawn FR2068412A1 (fr) 1969-10-21 1969-10-21

Country Status (7)

Country Link
US (1) US3737524A (fr)
JP (1) JPS502008B1 (fr)
BE (1) BE757653A (fr)
DE (1) DE2051745A1 (fr)
FR (1) FR2068412A1 (fr)
GB (1) GB1294580A (fr)
NL (1) NL7015376A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT347602B (de) * 1975-08-22 1979-01-10 Fresenius Chem Pharm Ind Mittel zur durchfuehrung eines harnsaeure- belastungstests
FR2353293A1 (fr) * 1976-06-03 1977-12-30 Beljanski Mirko Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines
DE2824411A1 (de) * 1978-06-03 1979-12-13 Boehringer Sohn Ingelheim Antiviral wirksame t-rna-praeparate
EP0063657A1 (fr) * 1981-04-29 1982-11-03 Merck & Co. Inc. Application topique d'inducteurs d'interféron
JPS59219235A (ja) * 1983-05-30 1984-12-10 Mitsui Toatsu Chem Inc 消化性潰瘍用剤
DE10065953A1 (de) * 2000-12-23 2002-07-04 Degussa Verfahren zur Erhöhung der inneren Stabilität von Natriumpercarbonat
EP2600901B1 (fr) 2010-08-06 2019-03-27 ModernaTX, Inc. Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale
ES2737960T3 (es) 2010-10-01 2020-01-17 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3682905B1 (fr) 2011-10-03 2021-12-01 ModernaTX, Inc. Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations
EP2791160B1 (fr) 2011-12-16 2022-03-02 ModernaTX, Inc. Compositions de mrna modifiés
AU2013243948A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP4074834A1 (fr) 2012-11-26 2022-10-19 ModernaTX, Inc. Arn à terminaison modifiée
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (fr) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucléotides codant des polypeptides de modulation immunitaire
CA2926218A1 (fr) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides codant pour un recepteur de lipoproteines de faible densite

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598619A1 (fr) * 1986-05-16 1987-11-20 Mafitra Management Services In Medicament antiviral a base d'acide nucleique modifie, et son procede de preparation

Also Published As

Publication number Publication date
GB1294580A (en) 1972-11-01
US3737524A (en) 1973-06-05
JPS502008B1 (fr) 1975-01-23
BE757653A (fr) 1971-04-16
NL7015376A (fr) 1971-04-23
DE2051745A1 (de) 1971-04-29

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU442535B2 (fr)
AU410358B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU428131B2 (fr)
AU417208B2 (fr)
AU442380B2 (fr)
AU438128B2 (fr)
AT308690B (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442357B2 (fr)
AU414607B2 (fr)
AU470661B1 (fr)
AU425297B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
CD Change of name or company name
TP Transmission of property
ST Notification of lapse